Day: January 6, 2026

– Positive Interim Results of Phase 1a Single (SAD) and Multiple Ascending Dose (MAD) Trial Reinforce Potential Best-in-Class Potency Advantage of ATI-052 – – Trial Results Support Potential for Extended Dosing of up to Every Three Months – – Initiation of Phase 1b Proof-of-Concept (POC) Trials in Atopic Dermatitis (AD) and Asthma Now Expected in First Quarter of 2026; Planning Underway for Advancement of ATI-052 into Phase 2b Trial in AD in the Second Half of 2026 – – Management to Host a Conference Call to Discuss Update Today at 8:00 AM EST – WAYNE, Pa., Jan. 06, 2026 (GLOBE NEWSWIRE) — Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage biopharmaceutical company focused on developing novel product candidates for immuno-inflammatory diseases, today announced positive interim...

BETHESDA, Md., Jan. 06, 2026 (GLOBE NEWSWIRE) — Liquidity Services (NASDAQ:LQDT), the leading global provider of e-commerce marketplaces and software solutions powering the circular economy, today announced that it expects to report its first quarter fiscal year 2026 results prior to market open on Thursday, February 5, 2026. Bill Angrick, Chairman and CEO, and Jorge Celaya, EVP and CFO, will then host a conference call to review the results at 10:30 AM Eastern Time. To participate in the conference call, please register here to receive the dial-in number and unique conference pin. A listen-only live webcast of the conference call will also be provided on the Company’s investor relations site. An archive of the webcast will be available on the Company’s website until February 5, 2027. To listen to the replay, visit the Liquidity...

Glo Fiber arriving in Zanesville, OhioThe Glo Fiber team is ready to start working in Zanesville, Ohio.EDINBURG, Va., Jan. 06, 2026 (GLOBE NEWSWIRE) — Glo Fiber, powered by Shenandoah Telecommunications Company (Shentel) (Nasdaq: SHEN), has launched their 100% fiber optic broadband service in initial neighborhoods in Zanesville, Ohio. Construction is expected to be completed by the summer of 2026, providing approximately 12,000 homes and businesses with a reliable, future-proof option for high-speed internet service. As construction continues, residents will receive advance notice via mail, and they can check availability or sign up for service at www.glofiber.com. “The successes that America has enjoyed for over 200 years have come largely from the benefits of competition and innovation in our economy. The Zanesville...

Drilling intersects new gold mineralisation south of existing pit shells, including a high-grade intercept of 39.3 g/t Au over 2.7m and 2.1 g/t Au over 30m. Significant gold mineralisation intercepted down-plunge of current gold resource including 4.0 g/t Au over 23.5m within 2.4 g/t Au over 50m. Major drill program initiated with five rigs committed to expanding gold zones. Greenfields exploration ongoing with assays pending from new target areas.TORONTO, Jan. 06, 2026 (GLOBE NEWSWIRE) — G2 Goldfields Inc. (“G2” or the “Company”) (TSX: GTWO; OTCQX: GUYGF) is pleased to announce new assay results from the Company’s ongoing diamond drill program at the OKO Project, Guyana (“OKO” or the “Project”). In December 2025, G2 released key findings from an independent Preliminary Economic Assessment (“PEA”) [see press release dated December...

TORONTO and FLIN FLON, Manitoba, Jan. 06, 2026 (GLOBE NEWSWIRE) — McEwen Inc. (“McEwen”) (NYSE/TSX:MUX) and Canadian Gold Corp. (“Canadian Gold”) (TSX-V:CGC) are pleased to announce the completion of the previously announced business combination between McEwen and Canadian Gold by way of statutory plan of arrangement (the “Arrangement”). Shareholders of Canadian Gold approved the Arrangement on December 5, 2025 and a final order approving the Arrangement was issued by the British Columbia Supreme Court on December 10, 2025, as amended by a further order of the British Columbia Supreme Court according to the Amending Agreement described below. The Arrangement was completed under the Business Corporations Act (British Columbia) and was deemed to become effective at 8:00 a.m. Vancouver time on January 5, 2026. Under the terms of the...

Cloud security service centers now equipped to mitigate up to 30 Tbps of attack volume Latest generation of DefensePro® X, Radware’s industry-leading DDoS mitigation platform allows for enhanced precision automation, speed and complex attack protection MAHWAH, N.J., Jan. 06, 2026 (GLOBE NEWSWIRE) — Radware® (NASDAQ: RDWR), a global leader in application security and delivery solutions for multi-cloud environments, announced that it has doubled the mitigation capacity of its global cloud security service network—from 15 Tbps to 30 Tbps of total attack mitigation power. “The global threat landscape is undergoing a seismic shift. Attackers are leveraging AI-driven tools, automation, and increasingly sophisticated botnets to launch massive, complex, highly disruptive, multi-vector DDoS campaigns that are harder to detect and mitigate,”...

Northwestern and Scripps Health join two previously announced sites in achieving this critical patient enrollment milestone Seven leading U.S. spine centers have now completed the regulatory and operational requirements to screen and enroll patients in CLARITY First readout on interim data expected after initial cohort of patients achieves 3-month follow up visit in 3Q 2026BROOMFIELD, Colo., Jan. 06, 2026 (GLOBE NEWSWIRE) — Aclarion, Inc., (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence (AI) algorithms to help physicians identify the location of chronic low back pain, today announced that Northwestern Medicine and Scripps Health have enrolled their first patients in the company’s pivotal CLARITY (Chronic Low bAck pain Randomized Independent Trial...

Phase 1b interim results of zumilokibart (APG777) in asthma demonstrated rapid and durable suppression of FeNO (key biomarker of Type 2 inflammation) through 16 weeks for all patients – Suppression of FeNO through 32 weeks for patients with available follow up – Results reinforce continued development in asthma testing every 3- or 6-month dosing Successful expansion of zumilokibart beyond dermatology confirms its pipeline-in-a-product potential across I&I indications Zumilokibart in atopic dermatitis (AD) advancing in Phase 2 APEX trials with goal of Phase 3 initiation by end of 2026:– Part A maintenance (52-week) data readout expected in Q1 2026 with potential to establish best-in-class every 3- or 6-month dosing profile– Part B enrollment completed ahead of schedule and exceeded enrollment target with a total...

ZUG, Switzerland, Jan. 06, 2026 (GLOBE NEWSWIRE) — Lithium Argentina AG (“Lithium Argentina” or the “Company”) (TSX: LAR) (NYSE: LAR) today announced preliminary 2025 operational results for the Cauchari-Olaroz lithium brine operation (“Cauchari-Olaroz”) in Jujuy, Argentina. Cauchari-Olaroz delivered strong and consistent operating performance through 2025, achieving production at the high end of annual guidance and record quarterly production in the fourth quarter. 2025 Operational Highlights:Achieved high-end of 2025 production guidance. Full-year 2025 production totaled approximately 34,100 tonnes of lithium carbonatei, within guidance of 30,000 – 35,000 tonnes. Record fourth quarter production. Fourth quarter 2025 production reached approximately 9,700 tonnes, with an average operating rate of 97% nameplate capacity. Cash...